Skip to main content
. 2020 Mar 25;10(4):124. doi: 10.3390/metabo10040124

Table 1.

Cohort characteristics.

Clinical Variables Control
(n = 426)
COPD
(n = 478)
PRISm
(n = 92)
Missing Spirometry
(n = 12)
Whole Cohort
(n = 1008)
Sex, % women 53.3 42.7 63 50 49.1
Race, % white 88.9 94.8 91.3 100 92.1
Former Smoker, % 73.7 77.6 70.7 66.7 75.2
Age (yr) 64.6 (58.3–71.5) 71.1 (64.9–76.6) 67.3 (60.9–72.9) 72 (68.2–75.3) 68 (61–74.6)
Body mass index (kg/m2) 28.4 (25.3–32.1) 27.4 (23.7–31.7) 30.8 (27.4–37.4) 27.8 (25.2–30.2) 28.1 (24.7–32.2)
Heart disease comorbidity (%) 30.3 50.2 38 50 40.7
FEV1% predicted 106.8 (11.7) 58(23.5) 70 (7.7) NA 77.4 (26.6) *
Percent emphysema
(% LAA < −950 HU)
2.2 (2.6) 12.8 (12.3) 1.5 (2.6) 9.2 (11.7) 7.1 (10.1) **

Data is presented as the median (interquartile range) for age and body mass index and mean (standard deviation) for FEV1% predicted and percent emphysema. The whole cohort is the combination of former and current smokers. PRISm: Preserved Ratio Impaired Spirometry defines individuals with a reduced FEV1 but with a preserved FEV1/FVC where FVC is forced vital capacity. GOLD: the global Obstructive Lung Disease system for grading COPD severity: GOLD 1 is early COPD, GOLD 2 is moderate COPD, GOLD 3 is severe COPD, GOLD 4 is very severe COPD, and GOLD 0 is an individual without COPD. Heart disease definition can be found in the Methods section. FEV1%: percent predicted forced expiratory volume in one second. Percent emphysema: percent of lung voxels less than −950 Hounsfield Units on inspiratory CT scans. * In total, 12 subjects were removed because they did not have FEV1 values. ** In total, 60 subjects were removed because they did not have percent emphysema values (12 control, 44 COPD, and 4 PRISm).